Clinical Status

Robust Clinical Pipeline

pipeline2022v2

*ALL = Acute Lymphoblastic Leukemia; NHL = Non-Hodgkin’s Lymphoma; CLL = Chronic Lymphocytic Leukemia; AML = Acute Myeloid Leukemia; DC = RNA-loaded Dendritic Cells; mRCC = Metastatic Renal Cell Carcinoma; MSK = Memorial Sloan Kettering Cancer Center; IST = Investigator sponsored trial; CST = Corporate sponsored trial

Programs